Effects of potassium channel knockdown on peripheral blood T lymphocytes and NFAT signaling pathway in Xinjiang Kazak patients with hypertension

References

• Mancusi C, Losi MA, Izzo R, Canciello G, Carlino MV, Albano G, De Luca N, Trimarco B, de Simone G. Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: the Campania salute network. Eur J Prev Cardiol. 2018;25(3):235–10. doi:10.1177/2047487317747498
   PubMed Web of Science ®Google Scholar
• Ye Y, Yang J, Lv W, Lu Y, Zhang L, Zhang Y, Musha Z, Fan P, Yang B, Zhou X, et al. Screening of differentially expressed microRNAs of essential hypertension in Uyghur population. Lipids Health Dis. 2019;18(1):98. doi:10.1186/s12944-019-1028-1.
   PubMedGoogle Scholar
• Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–50. doi:10.1161/CIRCULATIONAHA.115.018912
   PubMed Web of Science ®Google Scholar
• Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE million persons project). Lancet. 2017;390(10112):2549–58. doi:10.1016/S0140-6736(17)32478-9.
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang Z, Wang Y, Wang L, Han W, Tang Y, Xue F, Hou L, Liang S, Zhang B, et al. Prevalence, awareness, treatment, and control of hypertension among Kazakhs with high salt intake in Xinjiang, China: a community-based cross-sectional study. Sci Rep. 2017;7(1):45547. doi:10.1038/srep45547.
   PubMedGoogle Scholar
• Liu F, Ma Y, Yang Y, Xie X, Li X-M, Huang Y, Ma X, Chen B-D, Gao X, Du L. Epidemiological survey on the current status of hypertension in different ethnic groups in Xinjiang. Chin Med J. 2010;90(46):3259–62.
   Google Scholar
• Zhang Q, Mahapatra T, Huang F, Tang W, Guo Y, Tang S, Lei Y, Feng L, Wang A, Zhang L, et al. Association between anthropometric measures and indicators for hypertension control among Kazakh-Chinese hypertension patients in Xinjiang, China: results from a cross-sectional study. PLoS One. 2017;12(1):e0170959. doi:10.1371/journal.pone.0170959.
   PubMed Web of Science ®Google Scholar
• Ma S, Yang L, Zhao M, Magnussen CG, Xi B. Trends in hypertension prevalence, awareness, treatment and control rates among Chinese adults, 1991-2015. J Hypertens. 2021;39(4):740–48. doi:10.1097/hjh.0000000000002698
   PubMed Web of Science ®Google Scholar
• Li T, Song X, Wu J, Li Z, Li L, Yu Y, Wells GA, Liu B. Awareness of hypertension and related factors in northeastern China: a cross-sectional study. J Hum Hypertens. 2020;34(1):43–50. doi:10.1038/s41371-019-0263-2
   PubMed Web of Science ®Google Scholar
• Andriolo V, Dietrich S, Knüppel S, Bernigau W, Boeing H. Traditional risk factors for essential hypertension: analysis of their specific combinations in the EPIC-Potsdam cohort. Sci Rep. 2019;9(1):1501. doi:10.1038/s41598-019-38783-5
   PubMedGoogle Scholar
• Solak Y, Afsar B, Vaziri ND, Aslan G, Yalcin CE, Covic A, Kanbay M. Hypertension as an autoimmune and inflammatory disease. Hypertens Res. 2016;39(8):567–73. doi:10.1038/hr.2016.35
   PubMed Web of Science ®Google Scholar
• Biancardi VC, Bomfim GF, Reis WL, Al-Gassimi S, Nunes KP. The interplay between angiotensin II, TLR4 and hypertension. Pharmacol Res. 2017;120:88–96. 10.1016/j.phrs.2017.03.017.
   PubMed Web of Science ®Google Scholar
• Ni X, Wang A, Zhang L, Shan LY, Zhang HC, Li L, Si JQ, Luo J, Li XZ, Ma KT. Up-regulation of gap junction in peripheral blood T lymphocytes contributes to the inflammatory response in essential hypertension. PLoS One. 2017;12(9):e0184773. doi:10.1371/journal.pone.0184773
   PubMed Web of Science ®Google Scholar
• Chen S, Agrawal DK. Dysregulation of T cell subsets in the pathogenesis of hypertension. Curr Hypertens Rep. 2015;17(2):8. doi:10.1007/s11906-014-0521-1
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204(10):2449–60. doi:10.1084/jem.20070657
   PubMed Web of Science ®Google Scholar
• Crowley SD, Song YS, Lin EE, Griffiths R, Kim HS, Ruiz P. Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2010;298(4):R1089–1097. doi:10.1152/ajpregu.00373.2009
   PubMed Web of Science ®Google Scholar
• Chen R, Yan J, Liu P, Wang Z, Wang C, Zhong W, Xu L. The role of nuclear factor of activated T cells in pulmonary arterial hypertension. Cell Cycle. 2017;16(6):508–14. doi:10.1080/15384101.2017.1281485
   PubMed Web of Science ®Google Scholar
• Nieves-Cintron M, Amberg GC, Nichols CB, Molkentin JD, Santana LF. Activation of NFATc3 down-regulates the beta1 subunit of large conductance, calcium-activated K+ channels in arterial smooth muscle and contributes to hypertension. J Biol Chem. 2007;282(5):3231–40. doi:10.1074/jbc.M608822200
   PubMed Web of Science ®Google Scholar
• Vianna-Jorge R, Suarez-Kurtz G. Potassium channels in T lymphocytes: therapeutic targets for autoimmune disorders? BioDrugs. 2004;18(5):329–41. doi:10.2165/00063030-200418050-00005
   PubMed Web of Science ®Google Scholar
• Trebak M, Kinet JP. Calcium signalling in T cells. Nat Rev Immunol. 2019;19(3):154–69. doi:10.1038/s41577-018-0110-7
   PubMed Web of Science ®Google Scholar
• Hogan PG. Calcium-NFAT transcriptional signalling in T cell activation and T cell exhaustion. Cell Calcium. 2017;63:66–69. 10.1016/j.ceca.2017.01.014.
   PubMed Web of Science ®Google Scholar
• Bremer S, Vethe NT, Skauby M, Kasbo M, Johansson ED, Midtvedt K, Bergan S. NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation. Br J Clin Pharmacol. 2017;83(11):2494–502. doi:10.1111/bcp.13367
   PubMed Web of Science ®Google Scholar
• Luo J, Zhang YM, Ma KT, Si JQ, Liang P. Difference in the expression of Kv channel in lymphocytes between spontaneously hypertensive rats and wistar rats. Sheng Li Xue Bao. 2010;62(4):382–86.
   PubMedGoogle Scholar
• Yan LJ, Yang HT, Duan HY, Wu JT, Fan XW, Wang SL, Qiu CG. Analysis on the relationship and mechanism of high blood pressure and vascular aging on the condition that the gender and age matches. Eur Rev Med Pharmacol Sci. 2017;21(3 Suppl):84–87.
   PubMedGoogle Scholar
• Dai XJ, Zhang YM, Hou XL. The expression of peripheral blood lymphocytes Kv1.3 channel in patients with hypertension in Xinjiang Kazakh. Zhonghua Gao Xue Ya Za Zhi. 2012;20:175–78.
   Google Scholar
• Zhang Q, Gou F, Zhang Y, He Y, He J, Peng L, Cheng L, Yuan Q, Zhang G, Huang S. Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan. Kardiol Pol. 2016;74(5):476–88. doi:10.5603/KP.a2015.0210
   PubMed Web of Science ®Google Scholar
• Şimşek B, Altay S, Özbilgin N, Onat A. Autoimmune activation as a determinant of atrial fibrillation among Turks: a prospective evaluation. Medicine (Baltimore). 2018;97(31):e11779. doi:10.1097/md.0000000000011779
   PubMed Web of Science ®Google Scholar
• Dai W, Zhang Z, Zhao S. Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study. Lipids Health Dis. 2018;17(3 Suppl):273. doi:10.1186/s12944-018-0923-1
   PubMedGoogle Scholar
• Slíva J, Charalambous C, Bultas J, Karetová D. A new strategy for the treatment of atherothrombosis - inhibition of inflammation. Physiol Res. 2019;68:S17–s30. 10.33549/physiolres.934327.
   PubMed Web of Science ®Google Scholar
• Del Pinto R, Ferri C. Inflammation-accelerated senescence and the cardiovascular system: mechanisms and perspectives. Int J Mol Sci. 2018;19(12):3701. doi:10.3390/ijms19123701
   PubMed Web of Science ®Google Scholar
• Czopek A, Moorhouse R, Guyonnet L, Farrah T, Lenoir O, Owen E, van Bragt J, Costello HM, Menolascina F, Baudrie V, et al. A novel role for myeloid endothelin-B receptors in hypertension. Eur Heart J. 2019;40(9):768–84. doi:10.1093/eurheartj/ehy881.
   PubMed Web of Science ®Google Scholar
• Kirabo A. A new paradigm of sodium regulation in inflammation and hypertension. Am J Physiol Regul Integr Comp Physiol. 2017;313(6):R706–R710. doi:10.1152/ajpregu.00250.2017
   PubMed Web of Science ®Google Scholar
• Rudemiller NP, Crowley SD. The role of chemokines in hypertension and consequent target organ damage. Pharmacol Res. 2017;119:404–11. 10.1016/j.phrs.2017.02.026.
   PubMed Web of Science ®Google Scholar
• Elsaafien K, Korim WS, Setiadi A, May CN, Yao ST. Chemoattraction and recruitment of activated immune cells, central autonomic control, and blood pressure regulation. Front Physiol. 2019;10:984. 10.3389/fphys.2019.00984.
   PubMed Web of Science ®Google Scholar
• Fung-Leung WP, Edwards W, Liu Y, Ngo K, Angsana J, Castro G, Wu N, Liu X, Swanson RV, Wickenden AD. T cell subset and stimulation strength-dependent modulation of T cell activation by Kv1.3 blockers. PLoS One. 2017;12(1):e0170102. doi:10.1371/journal.pone.0170102
   PubMed Web of Science ®Google Scholar
• Lioudyno V, Abdurasulova I, Negoreeva I, Stoliarov I, Kudriavtsev I, Serebryakova M, Klimenko V, Lioudyno M. A common genetic variant rs2821557 in KCNA3 is linked to the severity of multiple sclerosis. J Neurosci Res. 2021;99(1):200–08. doi:10.1002/jnr.24596
   PubMed Web of Science ®Google Scholar
• Di L, Srivastava S, Zhdanova O, Ding Y, Li Z, Wulff H, Lafaille M, Skolnik EY. Inhibition of the K + channel KCa3.1 ameliorates T cell–mediated colitis. Proc Natl Acad Sci U S A. 2010; 107(4):1541–46. doi:10.1073/pnas.0910133107.
   PubMed Web of Science ®Google Scholar
• Bengsch B, Wherry EJ. The importance of cooperation: partnerless NFAT induces T cell exhaustion. Immunity. 2015;42(2):203–05. doi:10.1016/j.immuni.2015.01.023
   PubMed Web of Science ®Google Scholar
• Kiani A, Rao A, Aramburu J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity. 2000;12(4):359–72. doi:10.1016/s1074-7613(00)80188-0
   PubMed Web of Science ®Google Scholar
• Singh DK, Dwivedi VP, Ranganathan A, Bishai WR, Van Kaer L, Das G. Blockade of the Kv1.3 K + channel enhances BCG vaccine efficacy by expanding central memory T lymphocytes. J Infect Dis. 2016;214(9):1456–64. doi:10.1093/infdis/jiw395
   PubMed Web of Science ®Google Scholar
• Singh DK, Dwivedi VP, Singh SP, Kumari A, Sharma SK, Ranganathan A, Kaer LV, Das G, Lewinsohn DM. Luteolin-mediated Kv1.3 K+ channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice. PLoS Pathog. 2020;16(9):e1008887. doi:10.1371/journal.ppat.1008887
   PubMed Web of Science ®Google Scholar
• Khodoun M, Chimote AA, Ilyas FZ, Duncan HJ, Moncrieffe H, Kant KS, Conforti L. Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus. Sci Adv. 2020;6. doi:10.1126/sciadv.abd1471.
   Web of Science ®Google Scholar
• Chiang EY, Li T, Jeet S, Peng I, Zhang J, Lee WP, DeVoss J, Caplazi P, Chen J, Warming S, et al. Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions. Nat Commun. 2017;8(1):14644. doi:10.1038/ncomms14644.
   PubMedGoogle Scholar
• Chimote AA, Hajdu P, Kottyan LC, Harley JB, Yun Y, Conforti L. Nanovesicle-targeted Kv1.3 knockdown in memory T cells suppresses CD40L expression and memory phenotype. J Autoimmun. 2016;69:86–93. 10.1016/j.jaut.2016.03.004.
   PubMed Web of Science ®Google Scholar
• Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Tamaki N, Tsutsui H. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res. 2007;30(6):541–48. doi:10.1291/hypres.30.541
   PubMed Web of Science ®Google Scholar
• Gibas-Dorna M, Nowak D, Piatek J, Pupek-Musialik D, Krauss H, Kopczynski P. Plasma ghrelin and interleukin-6 levels correlate with body mass index and arterial blood pressure in males with essential hypertension. J Physiol Pharmacol. 2015;66(3):367–72.
   PubMed Web of Science ®Google Scholar
• Kamat NV, Thabet SR, Xiao L, Saleh MA, Kirabo A, Madhur MS, Delpire E, Harrison DG, McDonough AA. Renal transporter activation during angiotensin-II hypertension is blunted in Interferon-γ −/− and Interleukin-17A −/− mice. Hypertension. 2015;65(3):569–76. doi:10.1161/hypertensionaha.114.04975
   PubMed Web of Science ®Google Scholar
• Lee JW, Oh JE, Rhee KJ, Yoo BS, Eom YW, Park SW, Lee JH, Son JW, Youn YJ, Ahn MS, et al. Co-treatment with interferon-gamma and 1-methyl tryptophan ameliorates cardiac fibrosis through cardiac myofibroblasts apoptosis. Mol Cell Biochem. 2019;458(1–2):197–205. doi:10.1007/s11010-019-03542-7.
   PubMed Web of Science ®Google Scholar